Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -16.27
- Piotroski Score 2.00
- Grade N/A
- Symbol (PLUR)
- Company Pluri Inc.
- Price $6.04
- Changes Percentage (-0.33%)
- Change -$0.02
- Day Low $5.54
- Day High $6.18
- Year High $8.48
Pluri Inc., a biotechnology company, focuses on the development of placenta-based cell therapy product candidates for the treatment of multiple inflammatory, muscle injuries, and hematologic conditions. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trials for the muscle recovery after surgery for hip fracture; in Phase II clinical trails for the treatment of acute respiratory distress syndrome associated with COVID-19; and in Phase I/II clinical trial for treatment of steroid-refractory graft versus host disease. It also develops PLX-R18 for incomplete hematopoietic recovery following hematopoietic cell transplantation, as well as a solution for the treatment of acute radiation syndrome. The company was formerly known as Pluristem Therapeutics Inc. and changed its name to Pluri Inc. in July 2022. Pluri Inc. was incorporated in 2001 and is based in Haifa, Israel.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/10/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$4.12
- Trailing P/E Ratio -1.41
- Forward P/E Ratio -1.41
- P/E Growth -1.41
- Net Income $-20,888,000
Income Statement
Quarterly
Annual
Latest News of PLUR
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
1 Top Tech Stock to Buy Hand Over Fist Before TSMC's Spending Splurge Begins
TSMC dominates the global foundry market with 62% share, poised for growth with AI influence. ASML, crucial for TSMC's advanced chips, anticipates revenue surge due to increased spending by chipmakers...
By Yahoo! Finance | 2 days ago -
Raspberry Pi Sales Jump as Customers Splurge on Computers, Semiconductors -- Update
Raspberry Pi Holdings experienced a significant sales increase in the first half due to high demand for computers and semiconductors amidst industry inventory challenges. Sales rose 61% to $144 millio...
By MarketWatch | 6 days ago -
On, Arc'teryx, Skechers see robust demand as consumers splurge on quality sporting goods
Consumers are willing to spend on quality running shoes and outdoor wear for value and innovation. Companies like Amer Sports and On are thriving, while Skechers focuses on comfort technology. Lululem...
By Yahoo! Finance | 2 weeks ago